Posted by Michael Wonder on 26 May 2021
Prime Therapeutics launches MedDrive, a first of its kind medical drug management program uniquely aligned with its Blue Plan clients
26 May 2021 - MedDrive to tackle the toughest challenges facing growing medical Rx drug spend, harness the multi-billion dollar potential savings in biosimilar market.
Today, Prime Therapeutics unveiled MedDrive a new medical drug management program that provides solutions to help its Blue Plan clients manage the high costs associated with medically billed drugs.
